Status:
UNKNOWN
Using Color Doppler US Artifact to Identify Tumor Markers
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Breast Cancer
Interventional Radiology
Eligibility:
FEMALE
Brief Summary
Before neoadjuvant chemotherapy (NACT) in cases of locally advanced breast cancer, malignant masses in the breast and biopsy-proven tumor involvement axillary lymph nodes are marked with metallic mark...
Detailed Description
Following an exhaustive review of the existing literature, the investigators have determined that their study stands as the first to show the utility of like blooming artifact appearance in color Dopp...
Eligibility Criteria
Inclusion
- patients who have breast cancer and will receive NACT,
- patients who are scheduled for breast-conserving surgery,
- those who are not allergic to metals
Exclusion
- patients with breast cancer for whom NACT is not planned,
- patients with bleeding disorders, patients with metallic allergies,
- patients with cooperation problems and those who cannot remain still during US
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06166173
Start Date
August 1 2023
End Date
January 1 2024
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medeniyet University
Istanbul, Turkey (Türkiye)